Home › Funds › ADAR1 Capital Management, LLC › COGT
ADAR1 Capital Management, LLC position in COGT
COGENT BIOSCIENCES INC · Health Care
ADAR1 Capital Management, LLC reported holding 392,422 shares of COGT (COGENT BIOSCIENCES INC) in its Q3 2026 13F filing — a position valued at US$12.6M, representing 0.69% of its reported portfolio and ranking #35 among its reported holdings. ADAR1 Capital Management, LLC has disclosed COGT holdings in 2 of the last 2 reported quarters, going back to Q2 2026.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How ADAR1 Capital Management, LLC's COGT position evolved
ADAR1 Capital Management, LLC first disclosed a stake in COGT in Q2 2026 at 12,200 shares (US$472K). The position peaked in Q3 2026 at 392,422 shares, worth US$12.6M. Across 2 filings, ADAR1 Capital Management, LLC increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 392,422 shares valued at US$12.6M — an increase of 380,222 shares quarter over quarter.. Notable position changes include a 3117% increase in Q3 2026 (shares fell 11% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2026 | 12.20K | $472.14K | New |
| Q3 2026 | 392.42K | $12.57M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About COGT and 13F data
COGT (COGENT BIOSCIENCES INC) is a Health Care company. 49 other funds we track also report a position in COGT — the largest reported positions include Fairmount Funds Management LLC (US$213.0M), DEERFIELD MANAGEMENT COMPANY, L.P. (US$193.7M), Kynam Capital Management, LP (US$121.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding COGT
- Fairmount Funds Management LLC 5.50M sh · $212.98M · Q2 2026
- DEERFIELD MANAGEMENT COMPANY, L.P. 5.01M sh · $193.74M · Q2 2026
- Kynam Capital Management, LP 3.79M sh · $121.43M · Q3 2026
- Commodore Capital LP 3.05M sh · $118.03M · Q2 2026
- Octagon Capital Advisors LP 2.35M sh · $90.94M · Q2 2026
- TCG Crossover Management, LLC 2.50M sh · $80.05M · Q3 2026
- Deep Track Capital, LP 2.50M sh · $80.05M · Q3 2026
- RTW INVESTMENTS, LP 2.31M sh · $73.93M · Q3 2026
- Venrock Adviser, LLC 1.64M sh · $63.55M · Q2 2026
- EMERALD ADVISERS, LLC 1.61M sh · $51.67M · Q3 2026
- Siren, L.L.C. 1.61M sh · $51.53M · Q3 2026
- SILVERARC CAPITAL MANAGEMENT, LLC 1.57M sh · $50.42M · Q3 2026
More on ADAR1 Capital Management, LLC
FAQ
How long has ADAR1 Capital Management, LLC held COGT?
ADAR1 Capital Management, LLC has disclosed COGT holdings in 2 of the last 2 reported quarters, going back to Q2 2026.
What is ADAR1 Capital Management, LLC's current position in COGT?
As of Q3 2026, ADAR1 Capital Management, LLC holds 392.42K shares of COGT (COGENT BIOSCIENCES INC), valued at $12.57M, representing 0.69% of its reported portfolio and ranking #35.
Has ADAR1 Capital Management, LLC been buying or selling COGT?
In the latest 13F filing (Q3 2026), ADAR1 Capital Management, LLC increased its position in COGT. The position peaked in Q3 2026 at 392.42K shares.
Which other funds hold COGT?
Other major institutional holders of COGT include Fairmount Funds Management LLC, DEERFIELD MANAGEMENT COMPANY, L.P., Kynam Capital Management, LP, among 49 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.